Format

Send to

Choose Destination
Cancer Treat Rev. 1990 Sep;17(2-3):243-6.

Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients.

Author information

1
Department of Internal Medicine, University Hospital, Göttingen, Federal Republic of Germany.

Abstract

Widespread local recurrence of breast cancer, untreatable by surgery or radiation therapy, can present a serious therapeutic problem predominantly in patients refractory to systemic therapy. In a phase I trial hexadecylphosphocholine, a new agent with high membrane affinity and antineoplastic activity was applied topically to affected skin areas of breast cancer patients. The results provide evidence that hexadecylphosphocholine may be an active agent in the topical treatment of skin metastases.

PMID:
2272039
DOI:
10.1016/0305-7372(90)90054-j
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center